Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

FDA Accepts Filing of NDA for IV Antibiotic Oritavancin with Priority Review Oritavancin  ( INN , also known as  LY333328 ) is a novel semi-...

Researchers in China have  disrupted the life cycle of the leading cause of cervical cancer  – the human papilloma virus – using a macrocy...

After studying how samples of GIST responded to various concentrations of the 89 drugs in the laboratory, Dr. Duensing and her colleagues ...

Researchers create promising compound for cancer treatment

In continuation of my update on pregabalin A report in the Feb. 13  New England Journal of Medicine  confirms previous studies sugges...

An    early stage study shows melatonin   a hormone that regulates the body's sleep and awake cycles  may have the potential to help s...

Extracts of the geranium plant Pelargonium sidoides inactivate human immunodeficiency virus type 1 (HIV-1) and prevent the virus from inv...

In continuation of my update on  Nilotinib The anticancer drug nilotinib induces clearance of the toxic protein alpha-synuclein from  ...

A new hepatitis C drug that can be taken as a pill once a day was approved by the U.S. Food and Drug Administration on Friday. The drug,...

An experimental drug could eventually offer a new treatment option for genital herpes, a common and incurable sexually transmitted infecti...

Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the a...

Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming ...

Prostate cancer is the most common form of cancer in men. Affecting about 1 in 6 men, it is the second deadliest cancer. Research has been...

Extracts from the birch tree have served for centuries as a traditional means of helping the damaged skin around wounds to regenerate mo...